Issues remaining in current neuroendovascular therapy for complex aneurysms

Yasushi Matsumoto, Ryushi Kondo, Hiroaki Shimizu, Akira Takahashi, Teiji Tominaga

Research output: Contribution to journalArticlepeer-review

Abstract

Cerebral aneurysm embolization using Guglielmi detachable coils has been approved for reimbursement in Japan since 1997; however, it was still considered an alternative treatment modality for the difficult open surgery. Thereafter, the advantages of using the endovascular procedure for ruptured intracranial aneurysms were reported in ISAT in 2002 and as a result this procedure became a big topic in aneurysm treatment. In November 2011, the Barrow Ruptured Aneurysm Trial also reported on the advantages afforded by the procedure, and it was concluded that "high-quality surgical clipping be available as an alternative treatment modality." Conversely, following the global trend towards endovascular aneurysm treatment, the craniotomy procedure has become an alternative treatment modality to be used only if conducting endovascular surgery is difficult. However, this indication status is only when dealing with general aneurysm treatment and there is no clear direction for difficult-to-treat cerebral aneurysms. Tailor-made treatment is needed ultimately, but I would like to consider a treatment strategy for difficult-to- treat cerebral aneurysms from the position of a certified endovascular treatment practitioner. There are still major issues remaining for wide neck aneurysms, giant aneurysms, aneurysms involving any arteries and partially thrombosed aneurysms. I would like to offer an overview of "the remaining issues in current neuroendovascular procedures" by presenting these cases.

Original languageEnglish
Pages (from-to)749-758
Number of pages10
JournalJapanese Journal of Neurosurgery
Volume22
Issue number10
DOIs
Publication statusPublished - 2013

Keywords

  • Aneurysm
  • Complex aneurysm
  • Endovascular therapy

Fingerprint

Dive into the research topics of 'Issues remaining in current neuroendovascular therapy for complex aneurysms'. Together they form a unique fingerprint.

Cite this